*  Carmustine in Treating Patients With Recurrent Malignant Glioma - Full Text View - ClinicalTrials.gov
Drug Information available for: Carmustine Genetic and Rare Diseases Information Center resources: Glioblastoma Glioma Brain ... Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to ... Carmustine in Treating Patients With Recurrent Malignant Glioma. This study has been completed. ... At the time of surgery, groups of 6 patients receive up to 8 polifeprosan 20 wafers containing increasing doses of carmustine ...
  https://clinicaltrials.gov/ct2/show/NCT00004028
*  DMOZ - Health: Pharmacy: Drugs and Medications: C: Carmustine
MedlinePlus: Carmustine Provides information on usage, precautions, side effects and brand names when available. Data provided ...
  http://dmoztools.net/Health/Pharmacy/Drugs_and_Medications/C/Carmustine/
*  O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors - Full Text View - ClinicalTrials.gov
O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors. This study has been completed. ... Drug Information available for: Carmustine Genetic and Rare Diseases Information Center resources: Glioma Medulloblastoma ... OUTLINE: This is a dose escalation study of carmustine.. Patients receive O6-benzylguanine IV over 1 hour, then, 1 hour later, ... Carmustine. O(6)-benzylguanine. Antineoplastic Agents, Alkylating. Alkylating Agents. Molecular Mechanisms of Pharmacological ...
  https://clinicaltrials.gov/ct2/show/NCT00003765
*  Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain - No Study Results...
Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain. This study has been ...
  https://clinicaltrials.gov/ct2/show/results/NCT00003348
*  DailyMed - BICNU - carmustine
CARMUSTINE (UNII: U68WG3173Y) (CARMUSTINE - UNII:U68WG3173Y). CARMUSTINE. 100 mg in 30 mL. ... BiCNU® (carmustine for injection). Each package includes a vial containing 100 mg carmustine and a vial containing 3 mL sterile ... The mechanism of action of carmustine is not fully understood. While carmustine alkylates DNA and RNA, it is not cross- ... BiCNU®(carmustine for injection) is indicated as palliative therapy as a single agent or in established combination therapy in ...
  https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6cbb63c-e0b1-43ee-ad6f-408da0772079
*  carmustine | PeaceHealth
Carmustine is used to treat brain tumors, Hodgkin's disease, multiple myeloma, and non-Hodgkin's lymphoma. Carmustine is ... Carmustine may also be used for purposes not listed... ... Carmustine is a cancer medicine that interferes with the growth ... What is carmustine?. Carmustine is a cancer medicine that interferes with the growth and spread of cancer cells in the body. ... How is carmustine given?. Carmustine is injected into a vein through an IV. A healthcare provider will give you this injection ...
  https://www.peacehealth.org/medical-topics/content/multum/d01342a1.html
*  Definition of carmustine implant - NCI Drug Dictionary - National Cancer Institute
... biodegradable wafer containing the agent carmustine with antineoplastic activity. Used to deliver drug directly into a brain ... the wafer is made of a biodegradable poly-anhydride copolymer and contains the nitrosourea carmustine. ... carmustine implant A synthetic, biodegradable wafer containing the agent carmustine with antineoplastic activity. Used to ... Carmustine also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect. Carmustine is ...
  https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-implant
*  Carmustine - Wikipedia
Carmustine is an orange-yellow solid medication used mainly for chemotherapy. It is a nitrogen mustard β-chloro-nitrosourea ... Carmustine for injection was marketed under the name BiCNU by Bristol-Myers Squibb and now[when?] by Emcure Pharmaceuticals.[ ... Carmustine (bis-chloroethylnitrosourea, BCNU, BiCNU) is a medication used mainly for chemotherapy It is a nitrogen mustard β- ... The disc allows for controlled release of carmustine in the extracellular fluid of the brain, thus eliminating the need for the ...
  https://en.wikipedia.org/wiki/Carmustine
*  Carmustine Implants in Treating Patients With Brain Metastases
No known hypersensitivity to carmustine or Gliadel wafers. - No other serious concurrent medical illness or infection. PRIOR ... OUTLINE: Patients receive up to 8 polifeprosan 20 with carmustine implants (Gliadel wafers). implanted in the resected tumor ... tumors undergoing surgical resection treated with polifeprosan 20 with carmustine. implant (Gliadel wafers).. - Determine the ...
  http://www.knowcancer.com/cancer-trials/NCT00003878/
*  Carmustine, BCNU injection - AHealthyMe - Blue Cross Blue Shield of Massachusetts
Carmustine, BCNU injection. What is this medicine?. CARMUSTINE, BCNU (kar MUS teen) is a chemotherapy drug. It interferes with ... an unusual or allergic reaction to carmustine, BCNU, other chemotherapy, other medicines, foods, dyes, or preservatives ...
  http://www.ahealthyme.com/Library/DiseasesConditions/Pediatric/Neurological/121,563
*  Carmustine Implants in Treating Patients With Brain Metastases - Full Text View - ClinicalTrials.gov
Carmustine Implants in Treating Patients With Brain Metastases. The safety and scientific validity of this study is the ... Carmustine. Antineoplastic Agents, Alkylating. Alkylating Agents. Molecular Mechanisms of Pharmacological Action. ... PURPOSE: Phase II trial to study the effectiveness of implanted carmustine wafers in treating patients who have brain ... OUTLINE: Patients receive up to 8 polifeprosan 20 with carmustine implants (Gliadel wafers) implanted in the resected tumor ...
  https://clinicaltrials.gov/show/NCT00003878%A0
*  Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma - Full Text View - ClinicalTrials.gov
Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma. The safety and scientific validity of ... Drug Information available for: Carmustine Irinotecan Irinotecan hydrochloride Genetic and Rare Diseases Information Center ... Determine the toxic effects of irinotecan and carmustine in these patients.. OUTLINE: This is a dose escalation study of ... Patients receive irinotecan IV over 90 minutes weekly on weeks 1-4 and carmustine IV over 1 hour on weeks 1-6. Treatment ...
  https://clinicaltrials.gov/show/NCT00002988
*  Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma | Guidance and guidelines | NICE
Evidence-based recommendations on carmustine implants Gliadel) and temozolomide (Temodal) for newly diagnosed high-grade glioma ... Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma. Technology appraisal guidance [ ... Evidence-based recommendations on carmustine implants (Gliadel) and temozolomide for treating newly diagnosed high-grade glioma ...
  https://www.nice.org.uk/guidance/TA121
*  Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma - Full Text...
Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma. The safety ... Patients receive carmustine IV over 4 hours on days -7 to -5, etoposide IV over 4 hours on day -4, and cyclophosphamide IV on ... Drug: carmustine Drug: cyclophosphamide Drug: etoposide Other: pharmacological study Procedure: autologous hematopoietic stem ... Drug Information available for: Carmustine Etoposide Genetic and Rare Diseases Information Center resources: Lymphosarcoma ...
  https://clinicaltrials.gov/show/NCT00641381?order=567
*  WSAVA 2001 - CARMUSTINE ASSOCIATED TO VINCRISTINE AND PREDNISONE IN THE TREATMENT OF CANINE LYMPHOMA
Carmustine can be an alternative option in the treatment of canine lymphoma. ... Cumulatives doses of carmustine ranged from 100 to 298 mg/m2. Six dogs (85,7%), achieved complete remission after induction ... Carmustine is a highly lipid-soluble chemotherapeutic agent in the nitrosourea subclass that rapidly crosses the blood-brain ... The dogs received 2 to 7 cycles chemotherapics with carmustine plus VCR (median 5) and 4 to 8 cycles (median 6) only with VCR. ...
  https://www.vin.com/VINDBPub/SearchPB/Proceedings/PR05000/PR00543.htm
*  Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma - Full...
Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma. The ... Drug Information available for: Carmustine Genetic and Rare Diseases Information Center resources: Glioblastoma Anaplastic ... Drug: polifeprosan 20 with carmustine implant Procedure: surgical procedure Radiation: iodine I 125 Phase 1 ... Following maximum tumor removal, iodine I 125 seeds and up to 8 polifeprosan 20 with carmustine implants (Gliadel wafers) are ...
  https://clinicaltrials.gov/ct2/show/study/NCT00003876?view=results
*  Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem...
Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem ... Carmustine (BCNU) 300 mg/m^2 Day -6, Etoposide 100 mg/m^2 Days -5 to -2, Cytarabine 100 mg/m^2 Days -5 to -2, and Melphalan 140 ... Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 ...
  https://clinicaltrials.gov/ct2/show/NCT00329030?term=NCT00329030&rank=1
*  BICNU (Carmustine) dosage, indication, interactions, side effects | EMPR - Cancer Therapy Advisor
Carmustine) drug information & product resources from MPR including dosage information, educational materials, & patient ... Carmustine 100mg/vial; lyophilized pwd for IV infusion after reconstitution and dilution; preservative-free. ...
  http://www.cancertherapyadvisor.com/bicnu/drug/2055/
*  Glioblastoma fed by middle meningeal artery and displaying cyst formation soon after repeated implantation of carmustine wafers...
Eight pieces of carmustine wafers were implanted in the tumor resection cavity at the first and second surgeries. The patient ... 3C and D). The cyst was opened to the basal cisterns and the carmustine wafers were removed at the third operation (Fig. 3E). ... Eight pieces of carmustine wafers were implanted in the tumor resection cavity. Pathological examinations of the tumor specimen ... Cyst formation is known to occur as an adverse event of carmustine wafer implantation for malignant gliomas (9), and there have ...
  https://www.spandidos-publications.com/mco/7/6/953